We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKinovo Plc Regulatory News (KINO)

Share Price Information for Kinovo Plc (KINO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -0.40 (-0.97%)
Spread: 2.00 (5.00%)
Open: 41.00
High: 41.00
Low: 41.00
Prev. Close: 41.40
KINO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Kinovo plc

8 Sep 2023 11:45

RNS Number : 8917L
Kinovo PLC
08 September 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Kinovo plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kinovo plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

7 September 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

-

NIL

-

(2) Cash-settled derivatives:

 

NIL

-

NIL

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

-

NIL

-

 

TOTAL:

NIL

-

NIL

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Share interests (10p ordinary shares)

 

Name of Kinovo Director

Number of Shares

% of issued shares

Sangita Shah

869,622

1.38%

David Bullen

1,397,726

2.22%

Clive Lovett

552,784

0.88%

 

---------

 

Options interests (10p ordinary shares)

 

 

David Bullen:

 

Scheme

Number of shares

Exercise Price

Date of grant

Vesting date

Expiry date

SIP (year 1)

10,285

17.5p

01/08/2020

31/07/2024

N/A

SIP (year 2)

5,294

34.0p

01/08/2021

31/07/2025

N/A

SIP (year 3)

7,660

23.5p

01/08/2022

31/07/2026

N/A

JSOP (1)

250,000

26.0p

21/12/2020

20/12/2023

N/A

JSOP (2)

1,414,286

35.0p

05/03/2021

04/03/2024

N/A

CSOP

85.714

35.0p

05/03/2021

04/03/2024

04/03/2031

 

 

 

Clive Lovett:

 

Scheme

Number of shares

Exercise Price

Date of grant

Vesting date

Expiry date

SIP (year 1)

10,285

17.5p

01/08/2020

31/07/2024

N/A

SIP (year 2)

5,294

34.0p

01/08/2021

31/07/2025

N/A

SIP (year 3)

7,660

23.5p

01/08/2022

31/07/2026

N/A

JSOP (2)

414,286

35.0p

05/03/2021

04/03/2024

N/A

CSOP

85.714

35.0p

05/03/2021

04/03/2024

04/03/2031

 

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

8 September 2023

Contact name:

Clive Lovett

Telephone number:

020 4548 4562

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBVLFBXKLXBBX
Date   Source Headline
25th Mar 20244:36 pmRNSExercise of Options, PDMR Shareholdings & TVR
11th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSUpdate on DCB Discontinued Operations
9th Feb 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFirst Half Trading Update
26th Sep 20232:30 pmRNSDirector/PDMR Shareholdings
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSStatement regarding Rule 2.8 announcement
19th Sep 202312:53 pmRNSNo intention to bid statement
19th Sep 202311:30 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
15th Sep 202311:43 amRNSForm 8.5 (EPT/RI)
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Neil Rooney
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - JTC Employer Solutions
13th Sep 20237:00 amRNSDecarbonisation Direct Award
12th Sep 20236:03 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20233:23 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20239:20 amRNSForm 8.5 (EPT/RI)
8th Sep 20234:30 pmRNSForm 8.3 - Kinovo plc - Fiduchi Trustees Ltd
8th Sep 202311:45 amRNSForm 8 (OPD) - Kinovo plc
8th Sep 20239:55 amRNSForm 8.3 - Kinovo Plc
7th Sep 20236:25 pmRNSForm 8.3 - Kinovo plc
7th Sep 202310:29 amRNSForm 8.3 - Kinovo plc - Amendment
7th Sep 20237:00 amRNSAdditional Framework Wins and Direct Award
5th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Michael Whitaker
5th Sep 202311:15 amRNSForm 8.3 - Kinovo plc
5th Sep 20238:34 amRNSForm 8.5 (EPT/RI)
5th Sep 20237:00 amRNSRenewal of Bank Facilities
4th Sep 202311:10 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
1st Sep 202312:51 pmRNSForm 8.3 - KINOVO PLC
1st Sep 202312:37 pmRNSForm 8 (OPD) (Rx3 Holdings Limited)
1st Sep 202311:00 amRNSStatement regarding possible offer
1st Sep 202310:26 amRNSForm 8.5 (EPT/RI)
31st Aug 20236:29 pmRNSTotal Voting Rights
31st Aug 20236:29 pmRNSForm 8.3 - Kinovo plc
31st Aug 20234:55 pmRNSForm 8.3 - Kinovo PLC
31st Aug 20239:53 amRNSForm 8.5 (EPT/RI)
31st Aug 20237:00 amRNSResult of AGM
30th Aug 202310:00 amRNSForm 8.5 (EPT/RI)
30th Aug 20237:00 amRNSPossible offer for Kinovo plc
29th Aug 20232:27 pmRNSForm 8.3 - Kinovo PLC
29th Aug 202310:31 amRNSForm 8.3 - KINOVO PLC
29th Aug 202310:08 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
25th Aug 20233:24 pmRNSForm 8.3 - Kinovo plc
25th Aug 202312:06 pmRNSForm 8.3 - Kinovo PLC
25th Aug 202311:54 amPRNForm 8.3 - Kinovo Plc
25th Aug 20239:10 amRNSForm 8.5 (EPT/RI)
25th Aug 20237:00 amRNSRule 2.9 announcement
25th Aug 20237:00 amRNSShare Incentive Plan, Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.